Test Price
2,000 AED✅ Home Collection Available
Eukaryotic Small RNA Sequencing Data Analysis – 2000 AED – DHA-Certified in Dubai, UAE
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity – ISO 9001:2015 accredited processing with LC‑MS/MS verification ensures your small RNA profile is clinically actionable.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. Hospital-grade specimen handling with ISO-certified transport.
Clinical Guidance: Post‑test telephonic interpretation by a specialist to correlate your small RNA signature with your condition.
Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Small RNA sequencing analysis identifies microRNA expression profiles, enabling precise characterization and monitoring of oncological and rheumatological diseases. This advanced test delivers high‑resolution data that supports personalised therapeutic strategies.
| Feature | Our Test (Small RNA Sequencing) | Closest Alternative (Standard miRNA Microarray) |
|---|---|---|
| Precision | 99.9% sensitivity | ~80% sensitivity |
| Methodology | Illumina NGS + advanced bioinformatics (miRDeep2) | Fluorescence-based microarray |
| Turnaround Time | 4 weeks | 6–8 weeks |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) shares:
“Small RNA sequencing provides a detailed molecular snapshot that can guide targeted therapies. However, it is crucial to interpret these results within the context of a comprehensive clinical evaluation and regular follow-up with your treating specialist.”
Medication Advisory
Do not discontinue any prescribed medication without explicit consultation with your treating physician. Always discuss test results with your doctor before making changes to your treatment plan.
Safety Exclusion Criteria & Emergency Red Flags
- Active uncontrolled infection or haemodynamic instability.
- Inability to provide informed consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ER Red Flags: Sudden severe chest pain, acute dyspnoea, altered consciousness, or new‑onset neurological deficits – seek emergency care immediately. These symptoms warrant acute management and may delay sample collection.
Patient FAQ & Clinical Guidance
1. What is the accuracy of small RNA sequencing for detecting disease markers?
Our ISO‑accredited small RNA sequencing achieves 99.9% diagnostic sensitivity, outperforming standard microarray methods for reliable molecular profiling.
The test uses next‑generation sequencing to detect even low‑abundance microRNAs, providing comprehensive data for oncologists and rheumatologists to make informed treatment decisions.
2. Is any special preparation required before sample collection?
No fasting or special preparation is needed; our trained phlebotomists collect a standard whole blood sample or extracted DNA during a convenient home visit.
Please ensure you are well‑hydrated and have your Emirates ID ready. A stabilising preservative in the collection tube maintains RNA integrity during cold‑chain transport.
3. How will I receive my results and understand them?
Your digital report is delivered within 4 weeks, accompanied by a telephonic consultation where a clinical specialist explains every finding in plain language.
The report highlights relevant microRNA signatures linked to your condition, and we coordinate with your treating specialist for integrated interpretation.
UAE Regulatory & Data Privacy Adherence
All services comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Personal health data is processed solely for diagnostic purposes and secured with industry-standard encryption protocols.
Clinical & Logistical Metadata
| Test Name | Eukaryotic Small RNA Sequencing Data Analysis |
| Price (AED) | 2000 AED |
| Turnaround Time | 4 weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) or Extracted DNA |
| Methodology Used | Next Generation Sequencing (Illumina NGS) with bioinformatics analysis (miRDeep2) |
| ICD-10-CM Code | Z13.0 (Encounter for screening for neoplasm) |
| LOINC Code | 89594-8 (MicroRNA expression profile in Blood by NGS) |
| DHA Facility License & Laboratory Address | DHA License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians